Vise Technologies
CDNA icon

Vise Technologies’s CareDx CDNA Stock Holding History

Vise Technologies’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$355K Buy
+5,466
New +$248K ﹤0.01% 1582

Other funds holding CDNA

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Gagnon Securities
Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
GA
Gagnon Advisors New York $182M AUM 52.04% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Burney Company
Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return
Lisanti Capital Growth
Lisanti Capital Growth New York $373M AUM 178.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
ARS Investment Partners
ARS Investment Partners New York $2.23B AUM 74.02% 1-Year Est. Return

Vise Technologies's CDNA Position: Q3 2026 in Review

Vise Technologies opened a new position in CareDx (CDNA) in Q3 2026: 5,466 shares worth $355K. The stake represents ﹤0.01% of the portfolio and ranks #1582 among its holdings.

96 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • Vise Technologies held 5,466 shares of CareDx worth $355K as of Q3 2026.
  • CareDx was a new Vise Technologies position in Q3 2026.
  • CareDx made up ﹤0.01% of Vise Technologies's portfolio in Q3 2026, its #1582 holding.
  • 96 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Vise Technologies's 13F filing for Q3 2026, filed 29 Oct 2026.